FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2592421557> ?p ?o ?g. }

• W2592421557 abstract "Abstract Abstract 250 Sickle cell disease and β-thalassemia continue to cause significant morbidity and mortality. Strategies to increase fetal hemoglobin (HbF) levels can ameliorate symptoms and improve the lives of patients with these diseases. While most previous studies have focused on induction of γ-globin gene expression as an approach to induce HbF, there is evidence that HbF may be post-transcriptionally regulated. For example, butyrate was shown to increase the translational efficiency of γ-globin mRNA and 5-azacytidine (5-Aza) induces HbF to a much greater degree than γ-globin mRNA steady state levels. These findings suggest that translational regulation may play an underappreciated yet important role in controlling HbF levels and that investigating the molecular mechanisms involved in this control may provide new therapeutic targets for HbF induction. We hypothesized that the Integrated Stress Response (ISR) pathway is involved in differentially regulating fetal and adult hemoglobin production. The ISR pathway has been shown to modulate globin protein synthesis in response to heme availability and other stresses. In the absence of heme, the heme-regulated inhibitor kinase phosphorylates eIF2α, downregulates general protein synthesis, but enables translation of a limited number of transcripts that are critical for coordinating the stress response. To test our hypothesis, we first evaluated the effects of salubrinal (Sal), a small molecule that activates ISR signaling by selectively inhibiting p-eIF2α dephosphorylation, in K562 cells. 3μM and 6μM Sal increased p-eIF2α and activated ISR signaling as evidenced by increased ATF4 and GADD34 protein levels and increased gene expression of ATF3 and CHOP, two transcriptional targets of ATF4. Once we verified that Sal increased p-eIF2α and ISR signaling, we extended testing to primary human erythroid cells to evaluate its effect on hemoglobin production. We first determined a dose range of Sal that increased p-eIF2α in primary cells without reducing cell viability. Both 3μM and 6μM Sal increased p-eIF2α and only reduced cell number by 15% when applied on days 15 and 18 of differentiation, the period of maximal hemoglobin synthesis. Next, we determined that 3μM and 6μM Sal slightly reduced γ-globin and β-globin steady state mRNA levels but did not change the γ/(γ+β) ratio relative to control. In contrast, Sal significantly induced HbF when evaluated by HPLC at the end of differentiation on day 20. Compared to untreated cells, 3μM Sal increased the percent HbF from 2.7% to 5.0% (1.8 fold) and 6μM Sal resulted in 12.9% HbF (4.7 fold) (n=4, p<0.05). The enhanced %HbF was due to increased HbF but also reduced HbA, providing evidence that HbF and HbA may be differentially or reciprocally regulated at the translational level. Importantly, Sal treatment did not significantly reduce the total hemoglobin content relative to the untreated control and did not alter cellular differentiation when assessed by flow cytometry for CD71 and CD235a. These results suggest that Sal increases HbF by a post-transcriptional mechanism potentially through ISR activation. Sal treatments earlier in the differentiation process (days 9 and 12) before considerable amounts of hemoglobin are synthesized failed to significantly increase HbF, further supporting this conclusion. We then evaluated whether Sal treatment could enhance HbF induction by known activators of γ-globin transcription, such as 5-Aza and hydroxyurea (HU). 200nM 5-Aza alone increased %HbF from 2.7% to 12.4%. When 200nM 5-Aza was combined with 3μM and 6μM Sal, the %HbF increased to 18.0% and 22.8%, respectively. Similarly, 10μM HU alone increased HbF from 2.9% to 4.9%, but co-treatment with 3μM and 6μM Sal increased HbF to 7.7% and 15.0%, respectively. For both HU and 5-Aza, combined treatment with Sal did not alter the γ/(γ+β) ratio from what was seen with HU or 5-Aza alone. Taken together, these results indicate that the novel method of HbF induction by Sal enhances the effect of transcriptional activators of γ-globin. In the future, utilization of transcriptional and translational mechanisms of HbF induction may provide an opportunity for combination therapy to achieve therapeutic HbF levels at reduced doses, thereby reducing toxicity. Disclosures: No relevant conflicts of interest to declare." @default.
• W2592421557 created "2017-03-16" @default.
• W2592421557 creator A5016323341 @default.
• W2592421557 creator A5029365172 @default.
• W2592421557 date "2012-11-16" @default.
• W2592421557 modified "2023-09-28" @default.
• W2592421557 title "Salubrinal Increases Human Fetal Hemoglobin Production Through a Post-Transcriptional Mechanism" @default.
• W2592421557 doi "https://doi.org/10.1182/blood.v120.21.250.250" @default.
• W2592421557 hasPublicationYear "2012" @default.
• W2592421557 type Work @default.
• W2592421557 sameAs 2592421557 @default.
• W2592421557 citedByCount "0" @default.
• W2592421557 crossrefType "journal-article" @default.
• W2592421557 hasAuthorship W2592421557A5016323341 @default.
• W2592421557 hasAuthorship W2592421557A5029365172 @default.
• W2592421557 hasConcept C104317684 @default.
• W2592421557 hasConcept C105580179 @default.
• W2592421557 hasConcept C125996951 @default.
• W2592421557 hasConcept C149364088 @default.
• W2592421557 hasConcept C172680121 @default.
• W2592421557 hasConcept C181199279 @default.
• W2592421557 hasConcept C2776217839 @default.
• W2592421557 hasConcept C2776317666 @default.
• W2592421557 hasConcept C2778917026 @default.
• W2592421557 hasConcept C2779234561 @default.
• W2592421557 hasConcept C2779638656 @default.
• W2592421557 hasConcept C54355233 @default.
• W2592421557 hasConcept C55493867 @default.
• W2592421557 hasConcept C62478195 @default.
• W2592421557 hasConcept C86803240 @default.
• W2592421557 hasConcept C95444343 @default.
• W2592421557 hasConceptScore W2592421557C104317684 @default.
• W2592421557 hasConceptScore W2592421557C105580179 @default.
• W2592421557 hasConceptScore W2592421557C125996951 @default.
• W2592421557 hasConceptScore W2592421557C149364088 @default.
• W2592421557 hasConceptScore W2592421557C172680121 @default.
• W2592421557 hasConceptScore W2592421557C181199279 @default.
• W2592421557 hasConceptScore W2592421557C2776217839 @default.
• W2592421557 hasConceptScore W2592421557C2776317666 @default.
• W2592421557 hasConceptScore W2592421557C2778917026 @default.
• W2592421557 hasConceptScore W2592421557C2779234561 @default.
• W2592421557 hasConceptScore W2592421557C2779638656 @default.
• W2592421557 hasConceptScore W2592421557C54355233 @default.
• W2592421557 hasConceptScore W2592421557C55493867 @default.
• W2592421557 hasConceptScore W2592421557C62478195 @default.
• W2592421557 hasConceptScore W2592421557C86803240 @default.
• W2592421557 hasConceptScore W2592421557C95444343 @default.
• W2592421557 hasLocation W25924215571 @default.
• W2592421557 hasOpenAccess W2592421557 @default.
• W2592421557 hasPrimaryLocation W25924215571 @default.
• W2592421557 hasRelatedWork W1514616303 @default.
• W2592421557 hasRelatedWork W2001898141 @default.
• W2592421557 hasRelatedWork W2046626624 @default.
• W2592421557 hasRelatedWork W2053030260 @default.
• W2592421557 hasRelatedWork W2075360124 @default.
• W2592421557 hasRelatedWork W2114780948 @default.
• W2592421557 hasRelatedWork W2133928174 @default.
• W2592421557 hasRelatedWork W2234096379 @default.
• W2592421557 hasRelatedWork W2519430831 @default.
• W2592421557 hasRelatedWork W2570973814 @default.
• W2592421557 hasRelatedWork W2575472700 @default.
• W2592421557 hasRelatedWork W2586426349 @default.
• W2592421557 hasRelatedWork W2586549774 @default.
• W2592421557 hasRelatedWork W2716493171 @default.
• W2592421557 hasRelatedWork W2791077224 @default.
• W2592421557 hasRelatedWork W2942608986 @default.
• W2592421557 hasRelatedWork W2980009970 @default.
• W2592421557 hasRelatedWork W2980540564 @default.
• W2592421557 hasRelatedWork W3158114776 @default.
• W2592421557 hasRelatedWork W2214170694 @default.
• W2592421557 isParatext "false" @default.
• W2592421557 isRetracted "false" @default.
• W2592421557 magId "2592421557" @default.
• W2592421557 workType "article" @default.